Toronto, Ontario--(Newsfile Corp. - September 11, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, turned heads at the 2025 Canadian Seating and Mobility Conference (CSMC), one of Canada's premier gatherings for rehabilitation professionals, clinicians, and mobility industry leaders.
Providers try Curio at Cheelcare's booth at the 2025 CSMC
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11847/265899_csmc1.jpg
Cheelcare presented its latest updates to the Companion power-assist system alongside the company's newest innovation, Curio - Cheelcare's complex rehab power wheelchair built on their patented robotic platform. Both devices are designed to provide wheelchair users with enhanced quality of life and independence.
Cheelcare's Sales Representative for Ontario Demonstrates Newest Companion Product Updates at 2025 CSMC
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11847/265899_csmc2.jpg
"CSMC is Canada's largest event for our industry and allows us to directly connect with the clinicians, providers, and assistive technology professionals who are on the front lines of mobility care," said Allan Boyd, Cheelcare's VP of Growth. "The response to both Companion and Curio has been very positive and highlights the demand for more innovative solutions in the mobility market."
About Cheelcare Inc.
Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic wheelchair, Cheelcare combines engineering excellence with human-centered design to improve quality of life.
For more information, please visit: www.cheelcare.ca.
For further information, please contact:
Allex Laurin, Director of Marketing
Cheelcare Inc.
Tel: 1-888-948-2680 x200
Email: alaurin@cheelcare.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265899
SOURCE: Cheelcare Inc.
